Association of increased serum glycated albumin levels with low coronary collateralization in type 2 diabetic patients with stable angina and chronic total occlusion

Cardiovascular Diabetology

Volumn 12, Issue 1, 2013, Pages

  Shen, Ying ^a   Lu, Lin ^a   Ding, Feng H ^a   Sun, Zhen ^a   Zhang, Rui Y ^a   Zhang, Qi ^a   Yang, Zheng K ^a   Hu, Jian ^a   Chen, Qiu J ^a   Shen, Wei F ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Coronary collateralization; Diabetes; Glycated albumin

Indexed keywords

GLYCOSYLATED ALBUMIN; HEMOGLOBIN A1C;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ANGIOGRAPHY; AREA UNDER THE CURVE; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; CORONARY ARTERY COLLATERAL CIRCULATION; DIABETIC PATIENT; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GLOMERULUS FILTRATION RATE; HEART INFARCTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; SMOKING; STABLE ANGINA PECTORIS;

AGED; ANGINA, STABLE; AREA UNDER CURVE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; COLLATERAL CIRCULATION; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY OCCLUSION; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; RISK FACTORS; ROC CURVE; SERUM ALBUMIN; UP-REGULATION;

EID: 84887360982     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-12-165     Document Type: Article

References (41)

1. Traupe T, Gloekler S, de Marchi SF, Werner GS, Seiler C. Assessment of the human coronary collateral circulation. Circulation 2010, 122(12):1210-1220. 10.1161/CIRCULATIONAHA.109.930651, 20855668.
2. Schaper W. Collateral circulation, past and present. Basic Res Cardiol 2009, 104(1):5-21. 10.1007/s00395-008-0760-x, 2755790, 19101749.
3. Habib GB, Heibig J, Forman SA, Brown BG, Roberts R, Terrin ML, Bolli R. the TIMI investigators: Influence of coronary collateral vessels on myocardial infarction size in humans: results of phase I Thrombolysis in Myocardial Infarction (TIMI) trial. Circulation 1991, 83(3):739-746. 10.1161/01.CIR.83.3.739, 1900223.
4. Meier P, Gloekler S, Zbinden R, Beckh S, de Marchi SF, Zbinden S, Wustmann K, Billinger M, Vogel R, Cook S, et al. Beneficial effects of recruitable collaterals, a 10-year follow-up study in patients with stable coronary artery disease undergoing quantitative collateral measurements. Circulation 2007, 116(9):975-983. 10.1161/CIRCULATIONAHA.107.703959, 17679611.
5. Meier P, Hemingway H, Lansky AJ, Knapp G, Pitt B, Seiler C. The impact of the collateral circulation on mortality: a meta-analysis. Eur Heart J 2012, 33(5):614-621. 10.1093/eurheartj/ehr308, 21969521.
6. Rocic P. Why is coronary collateral growth impaired in type II diabetes and the metabolic syndrome?. Vascul Pharmacol 2012, 57(5-6):179-186. 3359422, 22342811.
7. Turgut O, Yilmaz MB, Yalta K, Tandogan I, Yilmaz A. Prognostic relevance of coronary collateral circulation: clinical and epidemiological implications. Int J Cardiol 2009, 137(3):300-301. 10.1016/j.ijcard.2008.06.016, 18684526.
8. Vessieres E, Freidja ML, Loufrani L, Fassot C, Henrion D. Flow (shear stress)-mediated remodeling of resistance arteries in diabetes. Vascul Parmacol 2012, 57(5-6):173-178.
9. Tamarat R, Silvestre JS, Huijberts M, Benessiano J, Ebrahimian TG, Duriez M, Wautier MP, Wautier JL, Levy BI. Blockade of advanced glycation end-product formation restores ischemia-induced angiogenesis in diabetic mice. Proc Natl Acad Sci U S A 2003, 100(14):8555-8560. 10.1073/pnas.1236929100, 166267, 12805564.
10. Cohen MP, Ziyadeh FN, Chen S. Amadori-modified glycated serum proteins and accelerated atherosclerosis in diabetes: pathogenic and therapeutic implications. J Lab Clin Med 2006, 147(5):211-219. 10.1016/j.lab.2005.12.006, 1800931, 16697768.
11. Pu LJ, Lu L, Xu XW, Zhang RY, Zhang Q, Zhang JS, Hu J, Yang ZK, Ding FH, Chen QJ, et al. Value of serum glycated albumin and high-sensitivity C-reactive protein levels in the prediction of presence of coronary artery disease in patients with type 2 diabetes. Cardiovasc Diabetol 2006, 5:27. 10.1186/1475-2840-5-27, 1764721, 17178005.
12. Lu L, Pu LJ, Zhang Q, Wang LJ, Kang S, Zhang RY, Chen QJ, Wang JG, De Caterina R, Shen WF. Increased glycated albumin and decreased esRAGE levels are related to angiographic severity and extent of coronary artery disease in patients with type 2 diabetes. Atherosclerosis 2009, 206(2):540-545. 10.1016/j.atherosclerosis.2008.12.045, 19368923.
13. Furusyo N, Koga T, Ai M, Otokozawa S, Kohzuma T, Ikezaki H, Schaefer EJ, Hayashi J. Plasma glycated albumin level and atherosclerosis: results from the Kyushu and Okinawa Population Study (KOPS). Int J Cardiol 2013, 167(5):2066-2072. 10.1016/j.ijcard.2012.05.045, 22658569.
14. Shen Y, Pu LJ, Lu L, Zhang Q, Zhang RY, Shen WF. Glycated albumin is superior to hemoglobin A1c for evaluating the presence and severity of coronary artery disease in type 2 diabetic patients. Cardiology 2012, 123(2):84-90. 10.1159/000342055, 23018602.
15. Shen Y, Pu LJ, Lu L, Zhang Q, Zhang RY, Shen WF. Serum advanced glycation endproducts and receptors as prognostic biomarkers in diabetic undergoing coronary artery stent implantation. Can J Cardiol 2012, 28(6):737-743. 10.1016/j.cjca.2012.08.015, 23073352.
16. Biesenbach G, Pohanka E. Dialysis: glycated albumin or HbA1c in dialysis patients with diabetes?. Nature Reviews Nephology 2011, 7(9):490-492.
17. Shafi T, Sozio SM, Plantinga LC, Jaar BG, Kim ET, Parekh RS, Steffes MW, Powe NR, Coresh J, Selvin E. Serum fructosamine and glycated albumin and risk of mortality and clinical outcomes in hemodialysis patients. Diabetes Care 2013, 36(6):1522-1533. 10.2337/dc12-1896, 23250799.
18. Levin DC. Pathways and functional significance of the coronary collateral circulation. Circulation 1974, 50(4):831-837. 10.1161/01.CIR.50.4.831, 4425386.
19. Rentrop KP, Cohen M, Blanke H, Phillips RA. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 1985, 5(3):587-592. 10.1016/S0735-1097(85)80380-6, 3156171.
20. Fraker TD, Fihn SD, Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, Ferguson TB, Gardin JM, et al. 2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 guidelines for the management of patients with chronic stable angina. J Am Coll Cardiol 2007, 50(23):2264-2274. 10.1016/j.jacc.2007.08.002, 18061078.
21. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003, 26(Suppl 1):S5-S20. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.
22. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001, 285(19):2486-2497. 10.1001/jama.285.19.2486, 11368702, Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP).
23. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, Spertus JA, Costa F. American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112(17):2735-2752. 10.1161/CIRCULATIONAHA.105.169404, 16157765.
24. Kanazawa M, Yoshike N, Osaka T, Numba Y, Zimmet P, Inoue S. Criteria and classification of obesity in Japan and Asia-Oceania. Asia Pac J Clin Nutr 2002, 11(suppl 8):s732-s737.
25. Ellis SG, Vandormael MG, Cowley MJ, DiSciascio G, Deligonul U, Topol EJ, Bulle TM. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease: Implications for patient selection (Multivessel Angioplasty Prognosis Study Group). Circulation 1990, 82(4):1193-1202. 10.1161/01.CIR.82.4.1193, 2401060.
26. Hsu PC, Juo SH, Su HM, Chen SC, Tsai WC, Lai WT, Sheu SH, Lin TH. Predictor of poor coronary collaterals in chronic kidney disease population with significant coronary artery disease. BMC Nephrol 2012, 13:98. 10.1186/1471-2369-13-98, 3457843, 22935602.
27. Kadi H, Ozyurt H, Ceyhan K, Koc F, Celik A, Burucu T. The relationship between high-density lipoprotein cholesterol and coronary collateral circulation in patients with coronary artery disease. J Invest Med 2012, 60(5):808-812.
28. Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, Xu JS, Huang SM, Wang LN, Huang W, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 2006, 17(10):2937-2944. 10.1681/ASN.2006040368, 16988059.
29. Rodino-Janeiro BK, Gonzalez-Peteiro M, Ucieda-Somoza R, Gonzalez-Juanatey JR, Alvarez E. Glycated albumin, a precursor of advanced glycation end products, up-regulates NADPH oxidase and enhances oxidative stress in human endothelial cells: molecular correlate of diabetic vasculopathy. Diabetes Metab Res Rev 2010, 26(7):550-558. 10.1002/dmrr.1117, 20818804.
30. Rubenstein DA, Morton BE, Yin W. The combined effects of sidestream smoke extracts and glycated albumin on endothelial cells and platelets. Cardiovasc Diabetol 2010, 9:28. 10.1186/1475-2840-9-28, 2909174, 20604957.
31. Cohen MP, Shea E, Chen S, Shearman CW. Glycated albumin increases oxidase stress, activates NF-κB and extracellular signal-regulated kinase (ERK), and stimulates ERK-dependent transforming growth factor-beta 1 production in macrophage RAW cells. J Lab Clin Med 2003, 141(4):242-249. 10.1067/mlc.2003.27, 12677169.
32. Baraka-Vidot J, Guerin-Dubourg A, Dubois F, Payet B, Bourdon E, Rondeau P. New insights into deleterious impacts of in vivo glycation on albumin antioxidant activities. Biochim Biophys Acta 2013, 1830(6):3532-3541. 10.1016/j.bbagen.2013.01.019, 23376313.
33. Scheubel RJ, Kahrstedt S, Weber H, Holtz J, Friedrich I, Borgerman J, Silber RE, Simm A. Depression of progenitor cell function by advanced glycation endproducts (AGEs): potential relevance for impaired angiogenesis in advanced age and diabetes. Exp Gerontol 2006, 41(5):540-548. 10.1016/j.exger.2006.01.002, 16515851.
34. Li H, Zhang X, Guan X, Cui X, Wang Y, Chu H, Cheng M. Advanced glycation end products impair the migration, adhesion and secretion potentials of late endothelial progenitor cells. Cardiovasc Diabetol 2012, 11:46. 10.1186/1475-2840-11-46, 3403843, 22545734.
35. Sun C, Liang C, Ren Y, Zhen Y, He Z, Wang H, Tan H, Pan X, Wu Z. Advanced glycation end products depress function of endothelial progenitor cells via p38 and ERK1/2 mitogen-activated protein kinase pathways. Basic Res Cardiol 2009, 104(1):42-49. 10.1007/s00395-008-0738-8, 18622638.
36. Menegazzo L, Albiero M, Avogaro A, Fadini GP. Endothelial progenitor cells in diabetes mellitus. Biofactors 2012, 38(3):194-202. 10.1002/biof.1016, 22488933.
37. Yue WS, Lau KK, Siu CW, Wang M, Yan GH, Yiu KH, Tse HF. Impact of glycemic control on circulating endothelial progenitor cells and arterial stiffness in patients with type 2 diabetes mellitus. Cardiovasc Diabetol 2011, 10:113. 10.1186/1475-2840-10-113, 3258289, 22185563.
38. Xie SL, Li HY, Deng BQ, Luo NS, Geng DF, Wang JF, Nie RQ. Poor coronary collateral vessel development in patients with mild to moderate renal insufficiency. Clin Res Cardiol 2011, 100(3):227-233. 10.1007/s00392-010-0233-8, 20865265.
39. Kadi H, Ceyhan K, Sogut E, Koc F, Celik A, Onalan O, Sahin S. Mildly decreased glomerular filtration rate is associated with poor coronary collateral circulation in patients with coronary artery disease. Clin Cardiol 2011, 34(10):517-621.
40. Ying Y, Yang K, Liu Y, Chen QJ, Shen WF, Lu L, Zhang RY. A uremic solute, P-cresol, inhibits the proliferation of endothelial progenitor cells via the p38 pathway. Circ J 2011, 75(9):2252-2259. 10.1253/circj.CJ-11-0046, 21747198.
41. Lu L, Pu LJ, Xu XW, Zhang Q, Zhang RY, Zhang JS, Hu J, Yang ZK, Lu AK, Ding FH, Shen J, Chen QJ, Lou S, Fang DH, Shen WF. Association of serum levels of glycated albumin, C-reactive protein and tumor necrosis factor-alpha with the severity of coronary artery disease and renal impairment in patients with type 2 diabetes mellitus. Clin Biochem 2007, 40(11):810-816. 10.1016/j.clinbiochem.2007.03.022, 17499233.